HomeCVKD • NASDAQ
Cadrenal Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.73M | 51.39% |
Net income | -3.67M | -53.25% |
Net profit margin | — | — |
Earnings per share | -1.87 | 16.89% |
EBITDA | -3.73M | -51.41% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.57M | 10.59% |
Total assets | 5.98M | 9.55% |
Total liabilities | 1.68M | 14.65% |
Total equity | 4.30M | — |
Shares outstanding | 2.05M | — |
Price to book | 6.15 | — |
Return on assets | -134.02% | — |
Return on capital | -179.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.67M | -53.25% |
Cash from operations | -3.03M | -97.86% |
Cash from investing | 0.00 | — |
Cash from financing | 1.26M | — |
Net change in cash | -1.77M | -15.44% |
Free cash flow | -1.69M | -149.94% |
Previous close
$13.17
Day range
$12.92 - $13.24
Year range
$8.74 - $22.90
Market cap
26.88M USD
Avg Volume
27.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2022
Website
Employees
4
